Patent number: 12163952
Abstract: Provided herein are methods, compositions and articles of manufacture for use in connection with cell therapy involving the administration of one or more doses of a therapeutic T cell composition. The cells of the T cell composition express recombinant receptors such as chimeric receptors, e.g. chimeric antigen receptors (CARs) or other transgenic receptors such as T cell receptors (TCRs). Features of the provided embodiments, including the numbers of cells or units of cells administered and/or the potency of administered cells, provide various advantages, such as lower risk of toxicity in subjects administered the T cell compositions.
Type:
Grant
Filed:
February 27, 2018
Date of Patent:
December 10, 2024
Assignee:
Juno Therapeutics, Inc.
Inventors:
Brian Christin, Michael Gerard Covington, Kedar Himanshu Dave, Richard James Getto, Jr., Tom Kowski, Ryan P. Larson, Christopher Glen Ramsborg, Nikolaus Sebastian Trede, Clinton Weber, James Boyd Whitmore, Nathan Yee, Pascal Beauchesne, Travis Beckett, Samuel Charles Blackman, Nathaniel Chartrand, Mel Davis-Pickett, Mark Gilbert, Nathaniel Lambert, He Li, Mary Mallaney, Kathryn Lindsay Pollock, Valerie Odegard, Jeff Smith, Claire Sutherland, Andrew W. Walker